Abstract-In cardiac fibroblasts, angiotensin II (Ang II) induced a rapid increase in extracellular signal-regulated kinase (ERK) activity in a pertussis toxin-insensitive manner. This ERK activation was abolished by the G q -associated phospholipase C inhibitor U73122 but was insensitive to protein kinase C (PKC) inhibitors or PKC downregulation by phorbol ester. Intracellular Ca 2ϩ chelation by BAPTA-AM or TMB-8 abolished Ang II-induced ERK activation, whereas treatment with EGTA or nifedipine did not affect it. Ca 2ϩ ionophore A23187 also induced a rapid increase in ERK activity to an extent similar to that of Ang II stimulation. Calmodulin inhibitors (W7 and calmidazolium) and tyrosine kinase inhibitors (genistein and ST638) completely blocked ERK activation by Ang II and A23187. Both Ang II and A23187 caused a rapid increase in the binding of GTP to p21
N eonatal rat cardiac fibroblasts have abundant highaffinity angiotensin II (Ang II) receptors, which are classified pharmacologically as belonging to the Ang II type 1 receptor (AT 1 -R) subtype. 1,2 AT 1 -R stimulation was found to stimulate DNA synthesis and cell proliferation 1 and also increase the synthesis of extracellular matrix proteins, 3 suggesting that cardiac fibroblasts contribute to remodeling of the cardiac interstitium in a variety of physiological and pathological conditions. Ang II, acting via AT 1 -R, initiates early biochemical events, including rapid production of diacylglycerol and inositol 1,4,5-triphosphate by phospholipase C (PLC)-mediated hydrolysis of inositol phospholipids and activation of protein kinase C (PKC). 4 -6 Ang II also induces a rapid increase in expression of the growthassociated nuclear proto-oncogenes similar to cellular events by peptide growth factors and stimulates tyrosine phosphorylation of multiple substrates, including p44 and p42 mitogen-activated protein/extracellular signal-regulated kinases (ERKs). [7] [8] [9] [10] [11] [12] Although it was reported that PKC played a dominant role in the Ang II-induced activation of ERK in vascular smooth muscle cells (VSMCs) 13 or cardiac myocytes, 9 other studies indicated that calcium signaling rather than PKC plays a critical role for the ERK activation in these cells. 10 -12 Booz et al, 6 using cardiac fibroblasts, reported that Ang II activates ERK activity by both PKC-independent and -dependent pathways, with increases in intracellular Ca 2ϩ playing an important role in the PKC-independent pathway. Thus, because the signal transduction mechanism leading to ERK activation after Ang II stimulation has not been clearly defined, we attempted to examine the roles of various signaling molecules activated by Ang II through AT 1 -R using cardiac fibroblasts expressing abundant amounts of AT 1 -R. In this study, we propose a novel signaling pathway in cardiac fibroblasts by which AT 1 
-R signals to p21
Ras and subsequently to ERK mainly through the G q -coupled Ca 2ϩ /calmodulin system, and we propose that Pyk2/CAK␤/RAFTK activated downstream of Ca 2ϩ -sensitive tyrosine kinase plays an important role in the efficient activation of the AT 1 -R/Ras/ERK signaling pathway.
Methods

Materials
GF109203X, U73122, U73343, BAPTA-AM, genistein, ST638, and W7 were purchased from Calbiochem. TMB-8, nifedipine, and calmidazolium chloride were also purchased from Calbiochem. Antibodies were purchased from the following vendors: Upstate Biotechnology (4G10-HRP), Novagen (anti-T7-tag monoclonal antibody), Transduction Laboratories (Pyk2), and New England Biolabs (phospho-specific ERK). The cDNA encoding dominant negative mutant of Pyk2 lacking its kinase domain was from Dr J. Schlessinger (New York Medical Center), T7-epitope tagged ERK1 was from Dr S. Ohno (Yokohama City University), and the dominant negative mutant of Ras (RasN17) was from Dr T. Kurosaki (Kansai Medical University). All cDNAs were subcloned into pRK5 or pRS␣ eukaryotic expression vectors for stable transfection.
Cell Culture
Cardiac fibroblasts were prepared from ventricles of 1-day-old Wistar rats and grown as previously described; subcultured fibroblasts from passages 4 through 10, used in this experiment, were Ͼ99% fibroblasts. 14,15 Subconfluent cells were serum-starved for 24 hours and used for the experiments.
ERK Activity
ERK activity was determined as previously reported. 16, 17 Briefly, the cells lysed in the lysis buffer were centrifuged after brief sonication, and the supernatant was assayed with an ERK assay kit (Amersham) that measured the incorporation of [␥- 33 P]ATP into synthetic peptide (KRELVEPLTPAGEAPNQALLR) as a specific ERK substrate. For immunoblot of protein resolved by 9% SDS-PAGE, we used phospho-specific ERK antibody (New England Biolabs Inc) that detects p42 ERK and p44 ERK only when catalytically activated by phosphorylation at Tyr-204. 16, 17 
Analysis of GTP-Bound Ras
Cells were prelabeled with 0.1 mCi/mL carrier-free 32 Porthophosphate for 18 hours in phosphate-free DMEM. The reaction was terminated by aspirating the media, and cells were lysed in buffer containing 20 mmol/L Tris-HCl, 150 mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L EGTA, 1% Triton-X100, 2.5 mmol/L sodium pyrophosphate, 1 mmol/L ␤-glycerophosphate, 1 mmol/L Na 3 VO 4 , 1 g/mL leupeptin, 1 g/mL antipain, 0.2% (wt/vol) aprotinin, 1 g/mL chymostatin, and 1 g/mL PMSF. The supernatant was immunoprecipitated with anti-Ha-Ras-agarose conjugate (Santa Cruz Biotechnology Inc) for 90 minutes at 4°C. Rasassociated guanine nucleotides were eluted in 2 mmol/L EDTA, pH 8, 2 mmol/L DTT, 0.2% SDS, 0.5 mmol/L GTP, and 0.5 mmol/L GDP for 20 minutes at 65°C. Eluted GTP and GDP were separated on polyethyleneimine-cellulose plates by thin-layer chromatography using 1.2 mol/L ammonium formate and 0.8 mol/L HCL. Labeled nucleotides were quantified by densitometry.
Calcium Analysis
Cells were washed twice and loaded with 3 mol/L fura 2-AM in PBS containing 20 mmol/L HEPES, pH 7.2, 5.6 mmol/L glucose, 0.025% BSA, and 1 mmol/L CaCl 2 . After 45 minutes of incubation at 37°C, cells were washed and diluted to 10 6 cells/mL with the same buffer. Ca 2ϩ levels were measured by exciting the fura 2 at 340 nm and 380 nm and rationing the fluorescence intensities detected at Ϸ510 nm. From this ratio, the level of Ca 2ϩ was estimated using K d that is derived from calibration curves. [Ca 2ϩ ] i was calibrated and computed as described. 18 Transfection of DNA DNAs (5 to 10 g) was transfected with Lipofectamine Plus reagent according to the manufacturer's instructions (Gibco BRL) as previously reported 19 ; stably transfected cells were selected with geneticin.
Transfected Epitope-Tagged ERK
Cells were cotransfected with tagged p42 ERK cDNA expression plasmid together with the RasN17 with Lipofectamine. After 48 hours of incubation, cells were disrupted with brief sonication. The supernatant was incubated with anti-T7-tag antibody for 4 hours at 4°C, precipitated using protein A/G agarose, and resuspended in 40 L kinase buffer containing 18 mmol/L HEPES, pH 7.5, 10 mmol/L Mg(OAc) 2 , 50 mol/L ATP, 2 Ci [␥-
32 P]ATP (Amersham), and 20 g myelin basic protein for 20 minutes at 30°C. After incubation, the reaction was terminated by adding Laemmli sample buffer; the supernatant was boiled for 5 minutes and subjected to SDS-PAGE. The gel was washed with 7% acetic acid for 30 minutes and with 3% glycerol for 30 minutes, dried, and exposed.
Statistical Analysis
Results are expressed as meanϮSE. ANOVA and Fisher's protected least significant difference test were used for multigroup comparisons, with a value of PϽ0.05 considered significant.
Results
AT 1 -R-Induced ERK Activation Is Mediated by PLC Activation Through Pertussis Toxin-Insensitive G Protein
Ang II (100 nmol/L) stimulates ERK activity with a maximal increase (about 11-fold) at 5 to 10 minutes followed by a gradual decline ( Figure 1A ). Ang II-induced ERK activation was increased dose-dependently with a maximal peak at 100 nmol/L ( Figure 1B ), and this activation was blocked by 10 mol/L losartan but not by 10 mol/L PD123319 (data not shown). Subsequent ERK experiments were performed with 100 nmol/L Ang II stimulation for 8 minutes. Treatment with pertussis toxin (PTX) (1 g/mL) for 24 hours did not affect Ang II-induced ERK activation, whereas it markedly inhibited ERK activation induced by lysophosphatidic acid (LPA), which has been shown to use the G i -dependent pathway 20, 21 ( Figure 1C ). These findings were also confirmed by determination of tyrosine phosphorylation level of p42 ERK ( Figure 1D ). Although a single band was detected in immunoblotting with an anti-phospho-ERK antibody, we found in cardiac fibroblasts used in this study that p42 ERK rather than p44 ERK is dominantly present and tyrosine is phosphorylated by Ang II or EGF, which contrasted with EGF-induced phosphorylation of both p42 and p44 ERK in Cos-7 cells ( Figure 1E ). A similar pattern of phosphorylation of ERK was also observed when a different commercially available anti-phospho-ERK antibody (Promega) was used for the blot ( Figure 1E ). Pretreatment with the PLC inhibitor U73122 22 nearly abolished Ang II-induced ERK activity dose-dependently ( Figure 1F ), while a structurally similar derivative of U73122 (U73343), which does not inhibit PLC, failed to exert a similar effect, and ERK activation by 100 nmol/L phorbol 12-myristate 13-acetate (PMA) was not inhibited by U73122 (data not shown). from intracellular stores and PKC activation, respectively. 23 Therefore, we examined the effects of the PKC inhibitors GF109203X and calphostin C on Ang II-induced ERK activation. Pretreatment with GF109203X (1 mol/L) or calphostin C (50 nmol/L) completely inhibited ERK activation in response to 100 nmol/L PMA with no effects on basal ERK activity, whereas no significant inhibition was observed in Ang II-induced ERK activation ( Figure 2A ). These drugs also suppressed tyrosine phosphorylation of p42 ERK induced by PMA but not by Ang II ( Figure 2B ). Depletion of PKC by 24-hour incubation with 1 mol/L PMA partially inhibited (19Ϯ2.7%, PϽ0.05) Ang II-induced ERK activity (Figures 2A and 2B ). These data suggest that PKC-mediated pathways do not play a dominant role in Ang II-induced ERK activation and that GF109203X-, calphostin C-, and phorbol ester-sensitive PKC is not involved in this mechanism. Exposure of fibroblasts to Ang II markedly increased intracellular Ca 2ϩ levels, and this increase was blocked by pretreatment with the intracellular Ca 2ϩ chelator BAPTA-AM (10 mol/L) ( Figure 3A) but not by extracellular Ca 2ϩ chelation by EGTA (data not shown). As shown in Figure 3B , Ang II-induced ERK activation was completely inhibited by pretreatment with BAPTA-AM (10 mol/L) and TMB-8 (100 mol/L), commonly used as intracellular Ca 2ϩ chelators, but not by pretreatment with EGTA or blockade of L-type Ca 2ϩ channels with nifedipine. Elevation of cytosolic Ca 2ϩ activates a variety of enzymes through interaction with calmodulin. 24 To examine whether calmodulin mediates ERK activation in response to Ang II, fibroblasts were preincubated with the calmodulin inhibitors W7 (100 mol/L) and calmidazolium (10 mol/L). These drugs completely blocked Ang II-induced ERK activity with no effect on basal ERK activity, and the ERK activation induced by the Ca 2ϩ ionophore A23187 was also inhibited by these drugs ( Figure 3C ). On the other hand, these calmodulin inhibitors had no effect on Ang II-induced increase in intracellular Ca 2ϩ level (data not shown) or PMA-induced ERK activation ( Figure 3C ). These results suggest that Ang II stimulates ERK activity through a Ca 2ϩ /calmodulin-dependent mechanism. To determine whether tyrosine kinase activity is required for Ca 2ϩ -dependent ERK activation in response to Ang II, cells were pretreated with genistein (100 mol/L) and ST638 (100 mol/L), protein kinase inhibitors with a strong preference for tyrosine-specific kinases, 25, 26 and then stimulated with either Ang II or A23187. These inhibitors completely abolished both Ang II-and A23187-induced ERK activation with no effects on basal ERK activity ( Figure 4A ). Similar inhibitory effects were observed in Ang II-induced tyrosine phosphorylation of p42 ERK ( Figure 4B ). On the other hand, these tyrosine kinase inhibitors did not have any effect on Ang II-induced increase in intracellular Ca 2ϩ level (data not shown) or PMA-induced ERK activation ( Figure 4A and 4B) . These findings suggest that protein tyrosine kinases activated downstream of the Ca 2ϩ /calmodulin pathway are closely involved in Ang II-induced ERK activation.
Ang II Increases GTP-Bound Ras and Ang IIInduced ERK Activation is Dependent on Ras
Ang II (100 nmol/L) induced a rapid accumulation of GTP-bound p21
Ras that reached a maximum in 4 to 5 minutes (1.8Ϯ0.3-fold increase relative to control, nϭ4; Figure 5A ), gradually declined, and returned to the basal level within 20 minutes. Treatment with A23187 also elicited an increase in GTP-bound p21
Ras to a similar extent (1.7Ϯ0.3-fold increase relative to control, nϭ4; Figure 5A ). To examine whether activation of p21
Ras and ERK by Ang II requires similar upstream signaling, the effects of several signal transduction inhibitors were tested on Ang II-induced p21
Ras activation. Pretreatment with genistein (100 mol/L) and calmidazolium (10 mol/L) ( Figure 5A ), but not with PTX (1 g/mL for 24 hours) or calphostin C (50 nmol/L) (data not shown), completely prevented Ang II-induced p21
Ras activation with no effect on basal activity.
We further examined the role of Ras in the AT 1 -R/ERK cascade pharmacologically using manumycin, which is a Ras farnesyl-transferase inhibitor and effectively suppresses Ras biological functions. 27 Although the basal ERK activity was slightly increased by pretreatment with manumycin (10 mol/L), both AT 1 -R-and A23187-induced ERK activation were abolished by manumycin to a similar extent ( Figure 5B ). Furthermore, we investigated the effect of overexpression of the dominant negative Ras (RasN17). We transfected an epitope-tagged ERK with or without RasN17 into fibroblasts and treated cells with Ang II. It was very likely that both epitope-tagged ERK and RasN17 DNAs were transfected into the same cells, and the ERK immunoprecipitated with anti-epitope-tag antibody was able to reflect the effect of RasN17. In preliminary experiments, by examining the cotransfected ␤-galactosidase transgene activity, we found that the transfection efficiency of epitope-tagged ERK was not changed with or without the RasN17. As shown in Figure 5C , both Ang II-and A23187-induced ERK activation were completely abolished by cotransfection of RasN17, and EGF-induced ERK activation (well known to be dominantly mediated through Ras) was also inhibited by RasN17, whereas PMA-induced ERK activation was not affected in cells overexpressing RasN17.
Ang II-Dependent ERK Activation and GTP Loading of Ras Is Sensitive to Pyk2
We next examined the role of a Ca 2ϩ -sensitive tyrosine kinase, Pyk2, 28 in Ang II-mediated ERK signaling. Although it has been reported that Pyk2, also termed CAK␤ 29 or RAFTK, 30 was expressed at high levels mainly in cells of neuronal origin 28 -30 but not in cardiac muscle, 31 we found for the first time that Pyk2 was abundantly present in cardiac fibroblasts ( Figure 6A ) and that both Ang II and A23187 markedly stimulated tyrosine phosphorylation of Pyk 2 (Figure 6B) . The Ang II-induced Pyk2 activation was nearly abolished by Ca 2ϩ /calmodulin kinase inhibitor (W7) and chelation of intracellular Ca 2ϩ with BAPTA-AM ( Figure 6B ). W7 or BAPTA-AM alone had no effect on the basal phosphorylation level of Pyk2, and tyrosine phosphorylation of Pyk2 was very rapid and occurred before maximal activation of ERK by Ang II (5 minutes) (data not shown).
To investigate the involvement of Pyk2 in the Ang IIinduced Ras/ERK pathway, cells were stably transfected with a dominant negative mutant of Pyk2 (PKM) lacking its kinase domain 32 ( Figure 6A ). We obtained several cloned cells expressing PKM and selected the clone that most abundantly expressed the PKM ( Figure 6A ). AT 1 -R numbers in these clones were examined by the ligand binding assay using the membrane fraction, and its expression level was found to be comparable with that in the control cells (Table) . Ang II-induced elevation of intracellular Ca 2ϩ level in this cloned cell was comparable with that in the control cells (data not shown), and PMA-induced ERK activation that utilizes upstream pathways different from AT 1 -R-mediated ERK signaling was preserved in the transfectants ( Figure 6C ). Interestingly, overexpression of this mutant significantly attenuated Ang II-or A23187-induced ERK activities (36% and 38% inhibition compared with that in mock-transfected cells, PϽ0.01, respectively) and ERK tyrosine phosphorylation levels. We also examined the effect of PKM overexpression on GTP loading of Ras. Ang II-induced accumulation of GTP-bound Ras was significantly inhibited (47Ϯ3%, PϽ0.001, nϭ3) in cells overexpressing PKM compared with that in the mock-transfected cells ( Figure 6D ). These data suggest that Pyk2 plays a critical role in the efficient activation of the Ang II-induced Ras/ERK pathway in a Ca 2ϩ /calmodulin-sensitive manner.
Discussion
The present study demonstrates that in cardiac fibroblasts, Ang II-induced Ras/ERK activation is dominantly mediated by a G q -coupled Ca 2ϩ /calmodulin-dependent mechanism and that activation of Pyk2 that lies downstream of Ca 2ϩ /calmodulin signals plays an important role in this signaling pathway. Earlier studies using VSMCs 13 reported an involvement of PKC or Ca 2ϩ -insensitive tyrosine kinase in the AT 1 -R/ERK signaling pathway, whereas the critical role of intracellular Ca 2ϩ was also reported in VSMCs 12 or cardiac myocytes. 10,11 Booz et al 6 previously reported that in cardiac fibroblasts, Ang II induces ERK activity by both PKC-independent and -dependent pathways, with increases in intracellular Ca 2ϩ playing an important role in the PKC-independent pathway; this contrasts with our present data indicating the dominant role of a Ca 2ϩ -mediated pathway in Ang II-induced ERK activation. However, we also found that PKC depletion by prolonged PMA treatment had a minor effect on Ang IIinduced ERK activation, whereas the PKC inhibitors GF109203X and calphostin C, known to inhibit PKC-␣, -␤I, -␤II, and -␥, 33 had no effect on ERK activation by Ang II (Figure 2) . Thus, it might be possible that the pathway by which GF109203X-and calphostin C-or phorbol esterinsensitive isoforms of PKC such as PKC-transmit Ang II signaling to ERK is at least partially involved in Ang II-induced ERK activation, and that this PKC isoform is relatively downregulated in cells used in this study compared with that of Booz et al 6 because of the influence of passage numbers or the difference in experimental conditions. In the present study, we further extended the study by Booz et al 6 by examining the downstream pathway of Ca 2ϩ signaling and found for the first time that Pyk2 activated downstream of G q -coupled Ca 2ϩ /calmodulin signals plays an important role in the efficient activation of the AT 1 -R-mediated Ras/ERK signaling pathway.
Our present data demonstrated that both Ang II and A23187 activate p21
Ras and that the Ras-specific inhibitor manumycin and overexpression of the dominant negative mutant of Ras nearly abolished Ang II-or A23187-induced ERK activation. Ang II-induced p21
Ras activation was also blocked by either chelation of intracellular Ca 2ϩ or tyrosine kinase inhibitors, suggesting the presence of a common Ras/ERK pathway shared between Ang II and Ca 2ϩ signaling. It was reported that the adaptor protein Shc activated by receptor or nonreceptor tyrosine kinases is involved in the Ras/ERK signaling pathway. 34 Tyrosine-phosphorylated Shc can activate p21
Ras by binding to the SH2 domain of adaptor protein Grb2, which is complexed to the guanine nucleotide exchange factor Sos through its SH3 domains. Recently, Schorb et al 7 reported that Ang II phosphorylates p46
Shc and p56
Shc in cardiac fibroblasts. In addition, Ang II-induced Shc phosphorylation resulted in the subsequent formation of a complex between Shc and Grb2 in cardiac myocytes 10 or VSMCs. 21 Taken together, these data suggest that Ca 2ϩ -dependent ERK activation by Ang II is mediated by the signaling pathway initiated by tyrosine phosphorylationmediated Shc-Grb2-Sos complex formation, resulting in the activation of p21
Ras . Cardiac fibroblasts stably transfected with expression vector alone (control) or a dominant negative mutant of Pyk2 (PKM) were serum-starved for 12 hours. Expression levels of the mutant PKM are shown in Figure 6A . Receptor characterization (nϭ6) was performed by saturation binding using membrane fractions and subsequent Scatchard analyses.
Ca
2ϩ -dependent activation of a novel focal adhesion kinase family protein tyrosine kinase, Pyk2, also termed CAK␤ 29 or RAFTK, 30 has been shown to mediate G q -coupled receptorstimulated ERK activation in neuronal cells 28 via a direct interaction with c-Src or association with Grb2. 32 In neuronal cells, association of p60 c-Src with Pyk2 mediates both Shc phosphorylation and ERK activation. 35 Although it has been reported that Pyk2 was expressed at high levels, mainly in cells of neuronal origin 28 -30 but not in cardiac muscle, 31 we found for the first time that Pyk2 was abundantly present in cardiac fibroblasts and that Ang II markedly stimulated tyrosine phosphorylation of Pyk2 in a Ca 2ϩ /calmodulinsensitive manner. Consistent with our observations, Brinson et al 36 also have very recently reported that Pyk2 is activated by Ang II in a nonneuronal cell type such as VSMCs. The detection of Pyk2 in cell lysates from cardiac fibroblasts, as well as the sensitivity of AT 1 -R-mediated ERK activation in this cell to the dominant negative mutants of Pyk2, suggests that a Pyk2-mediated mechanism of Ras activation may represent a paradigm for mitogenic signaling in a variety of nonneuronal cell types. Considering that dominant negative mutants of Pyk2 moderately inhibited Ang II-induced ERK activity in contrast with complete inhibition by a dominant negative mutant of Ras, it is likely that an unidentified pathway other than Pyk2 that transmits Ca 2ϩ signal to Ras activation exists in this signal transduction system. As indicated by the involvement of the platelet-derived growth factor receptor 21 or epidermal growth factor receptor 17, 37 in Ang II signaling in VSMCs or cardiac fibroblasts, Ang II-induced transactivation of growth factor receptors is likely involved in this signal transduction system, and Pyk2 may contribute at least partially to such a transactivation mechanism. The mechanism of Ca 2ϩ /calmodulin-mediated Pyk2 activation remains unclear, since Pyk2 lacks a calmodulin binding motif and is not directly activated by Ca 2ϩ . 28, 29 However, it was shown that in HEK-293 cells, Pyk2 activated in a Ca 2ϩ /calmodulin-dependent manner is involved in G i -and G qmediated ERK activation. 32 Taken together with the fact that a Ca 2ϩ /calmodulin-activated tyrosine kinase has been purified from bovine uterus, 38 these findings suggest the presence of a Ca 2ϩ /calmodulin effector protein to activate Pyk2. Further studies are required to completely elucidate the AT 1 -Rmediated Ca 2ϩ /calmodulin-dependent signaling pathway leading to activation of the Ras/ERK cascade.
